Cargando…
Tilavonemab in early Alzheimer’s disease: results from a phase 2, randomized, double-blind study
Tau accumulation in patients with Alzheimer’s disease tracks closely with cognitive decline and plays a role in the later stages of disease progression. This phase 2 study evaluated the safety and efficacy of tilavonemab, an anti-tau monoclonal antibody, in patients with early Alzheimer’s disease. I...
Autores principales: | Florian, Hana, Wang, Deli, Arnold, Steven E, Boada, Mercè, Guo, Qi, Jin, Ziyi, Zheng, Hui, Fisseha, Nahome, Kalluri, Hari Varun, Rendenbach-Mueller, Beatrice, Budur, Kumar, Gold, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10232284/ https://www.ncbi.nlm.nih.gov/pubmed/36730056 http://dx.doi.org/10.1093/brain/awad024 |
Ejemplares similares
-
A Comparative Study of a Novel Postural Garment Versus Exercise for Women with Nonspecific Cervical Pain: A Randomized Cross-over Trial
por: Avellanet, Merce, et al.
Publicado: (2021) -
Rizatriptan in migraineurs with unilateral cranial autonomic symptoms: a double-blind trial
por: Barbanti, Piero, et al.
Publicado: (2012) -
Comparison between methotrexate and apremilast in Psoriatic Arthritis-a single blind randomized controlled trial (APREMEPsA study)
por: Samanta, Joydeep, et al.
Publicado: (2023) -
Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine
por: Goadsby, Peter J, et al.
Publicado: (2019) -
Adjuvant use of melatonin for pain management in dysmenorrhea — a randomized double-blinded, placebo-controlled trial
por: Söderman, Lisa, et al.
Publicado: (2021)